Advances in point-of-care testing for new corona virus nucleic acid / 中国药科大学学报
Journal of China Pharmaceutical University
; (6): 635-645, 2020.
Article
in Zh
| WPRIM
| ID: wpr-843041
Responsible library:
WPRO
ABSTRACT
@#The corona virus disease 2019 (COVID-19) caused by the new coronavirus (SARS-CoV-2) has spread rapidly around the world,posing a serious threat to the public"s health. As of September 30,2020,the number of infected people in the world has reached 33 million,causing more than 1 million deaths. Normalized nucleic acid detection methods based on lab have long turnaround time and high cost. Therefore,there is an urgent need to develop a convenient method to detect SARS-CoV-2,so as to achieve rapid testing and timely control of the epidemic when resources are limited.This review summarizes the point-of-care testing (POCT) methods developed for SARS-CoV-2 in terms of extraction,amplification and detection,and briefly introduces commercial POCT instruments that integrate these three steps,in order to provide references for emergency response and rapid deployment of COVID-19 and other emerging infectious diseases.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Journal of China Pharmaceutical University
Year:
2020
Type:
Article